Skip to main content
. 2021 Sep 1;34(3):e14251. doi: 10.1111/nmo.14251

TABLE 1.

Prevalence of gastrointestinal symptoms among 147 patients hospitalized for COVID‐19 after a median 106 days of follow‐up

Gastrointestinal symptoms at most recent follow‐up appointment
Constipation Diarrhea Abdominal pain Nausea or vomiting Any symptoms
Sex
Female (n = 72) 4 4 10* 3 15 (21%)
Male (n = 75) 6 2 1* 3 9 (12%)
Age
18–44 (n = 24) 3 0 4 0 5 (21%)
45–59 (n = 36) 3 3 4 2 9 (25%)
60–69 (n = 34) 0 1 1 1 3 (8.8%)
≥70 (n = 53) 4 2 2 3 7 (13%)
Race
White (n = 37) 2 2 2 2 5 (14%)
Black (n = 27) 0 2 0 0 2 (7.4%)
Asian (n = 3) 1 0 1 0 2 (67%)
Other/decline (n = 80) 7 2 8 4 15 (19%)
Ethnicity
Hispanic (n = 83) 7 4 8 3 15 (18%)
Non‐Hispanic (n = 38) 2 2 1 1 5 (13%)
Unknown/decline (n = 26) 1 0 2 2 4 (15%)
Depression
No (n = 115) 7 3 7 4 15 (13%)*
Yes (n = 32) 3 3 4 2 9 (28%)*
Anxiety
No (n = 120) 7 5 7 5 19 (16%)
Yes (n = 27) 3 1 4 1 5 (19%)
Fibromyalgia
No (n = 128) 9 5 7* 6 19 (15%)
Yes (n = 19) 1 1 4* 0 5 (26%)
*

p < 0.05.